Sylvain Brisse
Génétique des Maladies Infectieuses
UMR CNRS/IRD No. 9926
Institut de Recherches pour le Dévelopement
Montpellier
France
Name/email consistency: high
- Evidence for genetic exchange and hybridization in Trypanosoma cruzi based on nucleotide sequences and molecular karyotype. Brisse, S., Henriksson, J., Barnabé, C., Douzery, E.J., Berkvens, D., Serrano, M., De Carvalho, M.R., Buck, G.A., Dujardin, J.C., Tibayrenc, M. Infect. Genet. Evol. (2003)
- Automated ribotyping of vancomycin-resistant Enterococcus faecium isolates. Brisse, S., Fussing, V., Ridwan, B., Verhoef, J., Willems, R.J. J. Clin. Microbiol. (2002)
- Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping. Brisse, S., Verhoef, J. Int. J. Syst. Evol. Microbiol. (2001)
- Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. Brisse, S., Verhoef, J., Tibayrenc, M. Int. J. Parasitol. (2001)
- Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. Brisse, S., Barnabé, C., Tibayrenc, M. Int. J. Parasitol. (2000)
- Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. Brisse, S., Milatovic, D., Fluit, A.C., Verhoef, J., Schmitz, F.J. Eur. J. Clin. Microbiol. Infect. Dis. (2000)
- Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. Brisse, S., Milatovic, D., Fluit, A.C., Kusters, K., Toelstra, A., Verhoef, J., Schmitz, F.J. J. Clin. Microbiol. (2000)
- Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. Brisse, S., Dujardin, J.C., Tibayrenc, M. Mol. Biochem. Parasitol. (2000)
- Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with alterations in GyrA and ParC proteins. Brisse, S., Milatovic, D., Fluit, A.C., Verhoef, J., Martin, N., Scheuring, S., Köhrer, K., Schmitz, F.J. Antimicrob. Agents Chemother. (1999)
- Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones. Brisse, S., Fluit, A.C., Wagner, U., Heisig, P., Milatovic, D., Verhoef, J., Scheuring, S., Köhrer, K., Schmitz, F.J. Antimicrob. Agents Chemother. (1999)